SEC Company Response from 1Life Healthcare Inc (CIK 0001404123) — Jul 14, 2021
1Life Healthcare Inc (CIK 0001404123)
Date: July 14, 2021 · CIK: 0001404123 · Accession: 0001193125-21-215220
AI Filing Summary & Sentiment
File numbers found in text: 333-257720, 814-0927
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Attn: Margaret Schwartz Re: 1Life Healthcare, Inc. Registration Statement on Form S-4 (File No. 333-257720)
Dear Ms. Schwartz:
This letter is sent on behalf of 1Life Healthcare, Inc. (the “Company”) in connection with the above-referenced Registration Statement on Form S-4 (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) by the Company pursuant to the Securities Act of 1933, as amended (the “Securities Act”). Pursuant to Rule 461 promulgated under the Securities Act, the Company hereby requests that the effective date of the Registration Statement be accelerated to 4:00 p.m., Eastern Time, on July 16, 2021, or as soon thereafter as practicable.
Please contact Matthew Hemington or Steven Tonsfeldt, each of Cooley LLP, at (650) 843-5062 or (650) 843-5967, respectively, with any questions you may have concerning this request. In addition, please notify Mr. Hemington or Mr. Tonsfeldt when the request for acceleration has been granted.
Sincerely,
1LIFE HEALTHCARE, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
1Life Healthcare, Inc.
One Embarcadero Center, Suite 1900
San Francisco, CA 94111
(415) 814-0927
July 14, 2021
VIA EDGAR
United States
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Margaret Schwartz
Re:
1Life Healthcare, Inc.
Registration Statement on Form S-4 (File No. 333-257720)
Dear Ms. Schwartz:
This letter is sent on behalf of 1Life Healthcare, Inc. (the “Company”) in connection with the above-referenced Registration Statement on Form
S-4 (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) by the Company pursuant to the Securities Act of 1933, as amended (the
“Securities Act”). Pursuant to Rule 461 promulgated under the Securities Act, the Company hereby requests that the effective date of the Registration Statement be accelerated to 4:00 p.m., Eastern Time, on July 16, 2021, or as
soon thereafter as practicable.
Please contact Matthew Hemington or Steven Tonsfeldt, each of Cooley LLP, at (650)
843-5062 or (650) 843-5967, respectively, with any questions you may have concerning this request. In addition, please notify Mr. Hemington or Mr. Tonsfeldt
when the request for acceleration has been granted.
Sincerely,
1LIFE HEALTHCARE, INC.
By:
/s/ Bjorn Thaler
Name:
Bjorn Thaler
Title:
Chief Financial Officer
cc:
Lisa Mango, 1Life Healthcare, Inc.
Ivy Tseng, 1Life Healthcare, Inc.
Matthew Hemington, Cooley LLP
Steven Tonsfeldt, Cooley LLP
Michael Ringler, Skadden, Arps, Slate, Meagher & Flom LLP
Dohyun Kim, Skadden, Arps, Slate, Meagher & Flom LLP